Recovery Housing For Drug Dependent Pregnant Women (HOME)

Johns Hopkins University

Status and phase: Completed; Phase 3; Phase 2

Conditions: Drug Addiction

Treatments: Behavioral: usual care; Behavioral: RBT

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT00497302

R01DA014979 (U.S. NIH Grant/Contract)

DPMCDA

Details and patient eligibility

About

For the past several years our research program has developed and tested an intensive outpatient intervention that is based in social learning theory and employs abstinence contingent access to recovery housing as a routine aspect of an intensive day treatment counseling program. The present project proposes to extend this treatment intervention to the special population of pregnant drug using women enrolled at the Center for Addiction and Pregnancy (CAP). We will compare an enhanced treatment that includes abstinence contingent recovery house living plus intensive individual therapy, to standard care at the CAP program. Specific aims of the project are derived from testing a two-group design are described below:

1. To determine whether financially supported abstinence-contingent recovery house placement plus individual counseling in pregnant drug-dependent women improves prenatal outpatient treatment retention.
2. To determine whether financially supported abstinence-contingent recovery house placement plus individual counseling in pregnant drug-dependent women reduces prenatal drug use.
3. To determine whether financially supported abstinence-contingent recovery house placement plus individual counseling results in better maternal and infant clinical birth outcomes (e.g., birth weight, estimated gestational age (EGA) at delivery, medical complications).

Enrollment: 128 patients

Sex: Female

Ages: 18 to 50 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• CAP enrolled
• Age 18 or older
• Evidence of use of opiate and/or cocaine use in the past 30 days
• Assigned to pharmacotherapy free modality
• CAP admission at an estimated gestational age (EGA) <34 weeks

Exclusion criteria

• Endorses current suicidal ideation
• Any medical disorders requiring extended or future hospitalization
• Meet diagnostic criteria for current DSM-IV alcohol dependence
• Meet diagnostic criteria for a current DSM-IV Axis I thought disorder (i.e. schizophrenia)
• Demonstrate significant cognitive impairment that precludes them from completing the initial assessment battery

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

128 participants in 2 patient groups

1

Experimental group

Description:

receives housing based on drug abstinence

Treatment:

Behavioral: RBT

2

Active Comparator group

Description:

Usual care treatment at the Center for Addiction and Pregnancy

Treatment:

Behavioral: usual care